S. Lee

发表

Phase I study of capecitabine in combination with cisplatin and irinotecan in patients with advanced solid malignancies

S. Eberhardt, C. Verschraegen, I. Rabinowitz, 2009, Investigational New Drugs.

Prediction of outcomes for patients with brain parenchymal metastases from breast cancer (BC): a new BC-specific prognostic model and a nomogram.

Sung-Bae Kim, J. Ahn, Yeon-Hee Park, 2012, Neuro-oncology.

Prospective analysis of quality of life in elderly patients treated with adjuvant chemotherapy for non-small-cell lung cancer.

Y. S. Kim, Sin-Ho Jung, M. Ahn, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

The impact of activated p-AKT expression on clinical outcomes in diffuse large B-cell lymphoma: a clinicopathological study of 262 cases.

Y. S. Kim, Y. Ko, M. Hong, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase II study of bevacizumab with liposomal doxorubicin for patients with platinum- and taxane-resistant ovarian cancer.

S. Eberhardt, C. Muller, C. Verschraegen, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Efficacy of palonosetron for the prevention of postoperative nausea and vomiting: a randomized, double-blinded, placebo-controlled trial.

H. Chun, S. Kang, S. Lee, 2014, British journal of anaesthesia.

Phase II study of theophylline in chronic lymphocytic leukemia: a study of the Eastern Cooperative Oncology Group (E4998)

J. Bennett, M. Tallman, E. Paietta, 2004, Leukemia.

Multicentre phase II trial of bevacizumab combined with docetaxel-carboplatin for the neoadjuvant treatment of triple-negative breast cancer (KCSG BR-0905).

Y. Im, S. Im, K. Jung, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Randomized phase III trial of high-dose interferon alfa-2b (HDI) for 4 weeks induction only in patients with intermediate- and high-risk melanoma (Intergroup trial E 1697) .

J. Kirkwood, M. Smylie, R. Kefford, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical relevance of TNM staging system according to breast cancer subtypes.

Y. Im, S. Nam, B. Han, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Metastatic Solid Tumors

C. Verschraegen, C. Sweeney, K. Feit, 2019 .

Alcohol consumption, glutathione S-transferase M1 and T1 genetic polymorphisms and breast cancer risk.

D. Noh, D. Kang, K. Yoo, 2000, Pharmacogenetics.

Modelling the early detection of breast cancer.

M Zelen, M. Zelen, S J Lee, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Resumption or persistence of menstruation after cytotoxic chemotherapy is a prognostic factor for poor disease-free survival in premenopausal patients with early breast cancer.

J. Ro, H. Han, H. Lee, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Heterogeneity of Triple Negative Breast Cancer (TNBC): TNBC Might Be Divided into Two or More Subgroups by Clinicopathologic Findings.

Jung-Hyun Yang, Sunshin Kim, Joonghyun Ahn, 2009 .

Phase II study of bevacizumab with liposomal doxorubicin for patients with platinum- and taxane-resistant ovarian cancer.

S. Eberhardt, C. Muller, C. Verschraegen, 2012 .

Breast cancer survivors of different sexual orientations : which factors explain survivors ’ quality of life and adjustment ?

Y. S. Kim, M. Ahn, S. Jung, 2013 .

A phase III, intergroup, randomized, double-blind, chemoprevention trial of selenium (Se) supplementation in resected stage I non-small cell lung cancer (NSCLC).

R. Marks, G. Goodman, G. Clamon, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical characteristics of triple-negative breast cancer.

M. Hur, H. Lee, J. Kim, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prospective analysis of quality of life in elderly patients treated with adjuvant chemotherapy for non-small-cell lung cancer.

Sin-Ho Jung, M. Ahn, Jong-Mu Sun, 2013, Annals of Oncology.

Resumption or persistence of menstruation after cytotoxic chemotherapy is a prognostic factor for poor disease-free survival in premenopausal patients with early breast cancer.

J. Ro, H. Han, H. Lee, 2012 .